Journal
RESPIROLOGY
Volume 16, Issue 6, Pages 900-911Publisher
WILEY
DOI: 10.1111/j.1440-1843.2011.02012.x
Keywords
asthma; clinical respiratory medicine; eosinophil
Categories
Funding
- GlaxoSmithKline
- AstraZeneca
- Novartis
- NHMRC
- Boehringer Ingelheim
- Pharmaxis
Ask authors/readers for more resources
Severe asthma affects 5-20% of the asthma population but is discordantly responsible for the major burden of illness and impairment to quality of life. Patients with severe asthma continue to experience ongoing symptoms despite maximal therapy. A severe asthma service provides a systematic approach to the management of the disease and aids in confirming the correct diagnosis, managing comorbid conditions that may mimic or aggravate asthma, and provides the environment to optimize treatment and asthma self-management skills and education. A severe asthma service is also the ideal environment for trialling add-on therapies and hence can improve patient outcomes and clinical practice. Within such a service there are many opportunities for training and research. In this articlewe describe the purpose of a severe asthma clinic, the necessary components of a service including staffing and facilities and the processes for trialling additional therapies used in the management of severe asthma.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available